W. Appel

1.1k total citations · 1 hit paper
13 papers, 620 citations indexed

About

W. Appel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Internal Medicine. According to data from OpenAlex, W. Appel has authored 13 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Internal Medicine. Recurrent topics in W. Appel's work include Lung Cancer Diagnosis and Treatment (3 papers), Pleural and Pulmonary Diseases (3 papers) and Occupational and environmental lung diseases (3 papers). W. Appel is often cited by papers focused on Lung Cancer Diagnosis and Treatment (3 papers), Pleural and Pulmonary Diseases (3 papers) and Occupational and environmental lung diseases (3 papers). W. Appel collaborates with scholars based in United Kingdom, Belgium and Spain. W. Appel's co-authors include Penella J. Woll, Corinne Faivre‐Finn, Linda Ashcroft, M. Snee, Jan P. van Meerbeeck, Fabrice Barlési, Jason Pantarotto, Andrea Bezjak, P. Fournel and Susan Harden and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and The Lancet Oncology.

In The Last Decade

W. Appel

11 papers receiving 607 citations

Hit Papers

Concurrent once-daily versus twice-daily chemoradiotherap... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Appel United Kingdom 7 395 274 252 106 84 13 620
V. Bishay United States 11 92 0.2× 276 1.0× 182 0.7× 82 0.8× 25 0.3× 44 748
Lorenzo Gervaso Italy 10 208 0.5× 110 0.4× 51 0.2× 202 1.9× 41 0.5× 46 447
Kenneth M. Algazy United States 8 195 0.5× 432 1.6× 32 0.1× 174 1.6× 40 0.5× 15 723
Anne K. Baumgärtner Germany 6 227 0.6× 194 0.7× 35 0.1× 35 0.3× 29 0.3× 9 451
Geneviève Bouchard‐Fortier Canada 15 117 0.3× 64 0.2× 182 0.7× 55 0.5× 39 0.5× 54 712
Xiaoli Zhu China 13 77 0.2× 125 0.5× 105 0.4× 38 0.4× 31 0.4× 39 459
Jason Wachsmann United States 9 124 0.3× 209 0.8× 33 0.1× 100 0.9× 41 0.5× 19 524
Fariba Saghafifar United States 5 190 0.5× 40 0.1× 38 0.2× 201 1.9× 174 2.1× 6 630
Kensuke Fukuda Japan 9 83 0.2× 161 0.6× 54 0.2× 58 0.5× 44 0.5× 45 377
Stefano Sanna Italy 12 182 0.5× 526 1.9× 46 0.2× 13 0.1× 43 0.5× 31 724

Countries citing papers authored by W. Appel

Since Specialization
Citations

This map shows the geographic impact of W. Appel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Appel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Appel more than expected).

Fields of papers citing papers by W. Appel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Appel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Appel. The network helps show where W. Appel may publish in the future.

Co-authorship network of co-authors of W. Appel

This figure shows the co-authorship network connecting the top 25 collaborators of W. Appel. A scholar is included among the top collaborators of W. Appel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Appel. W. Appel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bayman, N., W. Appel, Linda Ashcroft, et al.. (2019). Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial. Journal of Clinical Oncology. 37(14). 1200–1208. 36 indexed citations
2.
Bayman, N., W. Appel, Linda Ashcroft, et al.. (2018). Prophylactic irradiation of tracts (PIT) in patients with pleural mesothelioma: results of a multicentre phase III trial. Lung Cancer. 115. S30–S30.
4.
Faivre‐Finn, Corinne, M. Snee, Linda Ashcroft, et al.. (2017). Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. The Lancet Oncology. 18(8). 1116–1125. 354 indexed citations breakdown →
6.
Bayman, N., W. Appel, Linda Ashcroft, et al.. (2017). OA 02.03 Prophylactic Irradiation of Tracts (PIT) in Patients with Pleural Mesothelioma: Results of a Multicenter Phase III Trial. Journal of Thoracic Oncology. 12(11). S1747–S1747. 4 indexed citations
8.
Macbeth, Fergus, Simon Noble, Jessica Evans, et al.. (2015). Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial. Journal of Clinical Oncology. 34(5). 488–494. 134 indexed citations
9.
Dock, W, et al.. (1988). Fixed intravascular foreign bodies: a new method for removal.. Radiology. 167(2). 555–556. 20 indexed citations
10.
Schiessel, R, et al.. (1986). [Surgical therapy of Crohn disease and ulcerative colitis].. PubMed. 98(22). 769–74.
11.
Starlinger, M, W. Appel, M. Schemper, & R Schiessel. (1985). Long-Term Treatment of Peptic Esophageal Stenosis with Dilatation and Cimetidine: Factors Influencing Clinical Result. European Surgical Research. 17(4). 207–214. 14 indexed citations
12.
Ludwig, H, et al.. (1968). [Anticoagulants in the radiotherapy of genital carcinomas in women. I. Squamous cell carcinoma].. PubMed. 38. 2042–7. 4 indexed citations
13.
Appel, W.. (1951). [Hyperostosis of the skull in diabetics].. PubMed. 198(1). 61–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026